Equillium, Inc. (EQ): Price and Financial Metrics


Equillium, Inc. (EQ): $1.08

0.08 (+8.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EQ to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

EQ Stock Price Chart Interactive Chart >

Price chart for EQ

EQ Price/Volume Stats

Current price $1.08 52-week high $4.38
Prev. close $1.00 52-week low $0.79
Day low $0.99 Volume 37,376
Day high $1.09 Avg. volume 75,527
50-day MA $1.25 Dividend yield N/A
200-day MA $2.01 Market Cap 37.17M

Equillium, Inc. (EQ) Company Bio


Equillium Inc. is leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company is based in La Jolla, California.


EQ Latest News Stream


Event/Time News Detail
Loading, please wait...

EQ Latest Social Stream


Loading social stream, please wait...

View Full EQ Social Stream

Latest EQ News From Around the Web

Below are the latest news stories about EQUILLIUM INC that investors may wish to consider to help them evaluate EQ as an investment opportunity.

Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

LA JOLLA, Calif., January 13, 2023--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that an abstract was accepted for oral presentation at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy, and the Center for International Blood & Marrow Transplant Research. The Hybrid meetings will take place virtually

Yahoo | January 13, 2023

Equillium Inc. (NASDAQ: EQ) Is Down -36.14% In A Month. Could There Be Any Hope That It Will Rise Soon?

During the last session, Equillium Inc. (NASDAQ:EQ)’s traded shares were 0.32 million, with the beta value of the company hitting 1.27. At the end of the trading day, the stock’s price was $1.06, reflecting an intraday gain of 20.45% or $0.18. The 52-week high for the EQ share is $4.38, that puts it down -313.21 … Equillium Inc. (NASDAQ: EQ) Is Down -36.14% In A Month. Could There Be Any Hope That It Will Rise Soon? Read More »

Marketing Sentinel | December 31, 2022

Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday

With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Metacrine, Inc. (NASDAQ: MTCR ) and Equillium, Inc. (NASDAQ: EQ ) mutually agreed to terminate definitive merger agreement. Metacrine shares jumped 5.4% to $0.4551 in after-hours trading, while Equillium shares dropped 6.3% to close … Full story available on Benzinga.com

Benzinga | December 27, 2022

Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement

Equillium, Inc. (Nasdaq: EQ) and Metacrine, Inc. today announced the mutual termination of their previously announced definitive merger agreement. “Eq

Business Wire | December 23, 2022

Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement

LA JOLLA, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.

GlobeNewswire | December 23, 2022

Read More 'EQ' Stories Here

EQ Price Returns

1-mo 1.89%
3-mo -37.57%
6-mo -54.62%
1-year -72.45%
3-year -76.37%
5-year N/A
YTD 1.89%
2022 -71.88%
2021 -29.53%
2020 58.28%
2019 -58.58%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.597 seconds.